Zymeworks - Stock Price History | ZYME
Historical daily share price chart and data for Zymeworks since 2023 adjusted for splits. The latest closing stock price for Zymeworks as of June 09, 2023 is 8.52.
- The all-time high Zymeworks stock closing price was 56.81 on January 08, 2021.
- The Zymeworks 52-week high stock price is 10.80, which is 26.8% above the current share price.
- The Zymeworks 52-week low stock price is 4.11, which is 51.8% below the current share price.
- The average Zymeworks stock price for the last 52 weeks is 7.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zymeworks Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
6.9960 |
16.9800 |
16.9800 |
4.6500 |
7.8600 |
-52.04% |
| 2021 |
31.5066 |
48.9700 |
56.8100 |
15.1900 |
16.3900 |
-65.32% |
| 2020 |
39.6340 |
47.5900 |
54.9900 |
24.2800 |
47.2600 |
3.96% |
| 2019 |
23.9340 |
14.6900 |
45.4600 |
14.0200 |
45.4600 |
209.67% |
| 2018 |
13.4640 |
7.9332 |
21.8600 |
7.9332 |
14.6800 |
93.33% |
| 2017 |
8.8343 |
13.0000 |
13.2800 |
6.4800 |
7.5931 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.560B |
$0.412B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
